Loading company
Northwest Biotherapeutics Inc.
NWBO · OTC
Figures through September 30, 2026, from the 10-Q filed November 13, 2026
Built from Northwest Biotherapeutics Inc.’s own filings with the U.S. Securities and Exchange Commission (SEC). Figures are as reported, with per-share history restated onto today’s share basis. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.
NWBO · OTC
Figures through September 30, 2026, from the 10-Q filed November 13, 2026
Grade B
The band under the price shows the grade on each date, built only from filings that were public by then.
There is no grade history to chart for Northwest Biotherapeutics Inc. yet. The quarterly grade is rebuilt from only the filings that were public at the time, and this company has not yet reported enough of them to score a single quarter.